m.LearnBecome a PartnerBecome a Partner
m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
m.Stock by Mirae Asset
LoginOpen Demat Account
Mercury Laboratories Ltd logo

Mercury Laboratories Ltd Share Price

Current price unavailable.
As on - | -
PharmaceuticalsSmall Cap
BuySell

Volume Analysis

SPOT Pivot Levels

TypeClassicFibonacci
R1 --
R2--
R3--
PP- -
S1--
S2--
S3 --

Ratios

ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
ROCE-11.49-8.83-
ROE-8.81-5.87-
EPS8.3113.698.069.259.94

Peer Comparison

No data available
Scrip NamePriceDaily changeM CapPE Ratio1 Year Return

Corporate Action

April 29, 2026
Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyMercury Laboratories Ltd
2CIN NO.L74239MH1982PLC026341
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 7.31
4Highest Credit Rating during the previous FY BBplus
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD.
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



Name of the Company Secretary: Krishna Shah
Designation: Company Secretary and Compliance Officer
EmailId: secretarial@mercurylabs.com
Name of the Chief Financial Officer: Ashish Vasavada
Designation: Chief Financial Officer
EmailId: cfo@mercurylabs.com

Date: 29/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
April 29, 2026
Intimation of Resignation of SM Plant head jarod attched
April 29, 2026
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Mercury Laboratories Ltd
2 CIN NO. L74239MH1982PLC026341
3 Report filed for FY 2025-2026
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 2025-26 26-27
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) NA
8Quantum of (d) which has been met from (c)(e)* NA
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* NA


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)2024-25 25-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Krishna Shah
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Ashish Vasavada
Designation : -Chief Financial Officer

Date: 29/04/2026

About Mercury Laboratories Ltd

Equity img
Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962. Subsequently, it converted into Private Limited Company & incorporated in February, 1982. Later, it converted into Limited Company in 1992 in Maharashtra. The Company has obtained ISO 9001:2008 registrations. It is engaged into the manufacturing and export of wide range of Pharmaceutical item...
ISIN :INE947G01011

Registered Office

1st Floor 18 Shreeji Bhuwan 51,Princess Street Mangaladas Rd

Contact number

+ 91-22-66372841

Email

Registrars

Link Intime India Pvt Ltd
B-102&103 Shangrila Complex First Floor Akota Vadodara - 390 020

Contact number

+ 91-265-2356573/23567

Email

Management

SANJAY SHANTILAL PATEL (Chairman)

Rajendra R Shah (Director)

Open IPO’s

View All

FAQs

The share price of Mercury Laboratories Ltd on the BSE is - as on -

Note : Securities shown above are only for illustrative purposes and not recommendatory in nature. The data represents best/cumulative figures till date.